西方現代科技八股文與中文起承轉合在醫學論文寫作應

Stereotyped Writing in Contemporary Science and Technology: Exploring the Application of a Traditional Chinese Writing Format to Contemporary Medical Writing

10.7023/TJFM.201206.0096

蔡崇煌(Chung-Huang Tsai)；蔡新聲(Hsin-Sheng Tsay)；黃青真(Ching-Jang Huang)；林哲鈺(James Che-Yu Lin)；張金堅(King-Jen Chang)；李孟智(Meng-Chih Lee)

examination ； style ； medical journal ； IMRAD ； teaching on writing methods

台灣家庭醫學雜誌

22卷2期（2012 / 06 / 01）

96 - 106

繁體中文

八股文是明、清兩代科舉考試的一種文體，其有一些弊端，因此八股思想及八股文是污名代名詞，然八股文亦並非全然一文不值，其起承轉合的概念還是值得效法。本文將八股文做一簡單回顧，並用實際的國際醫學期刊做範例，說明起承轉合之應用格式，將中國古代八股文一詞，應用於現代科技論文固定的格式，賦予八股文一詞另一有用之生命。本文針對科技論文固定格式IMRAD（Introduction、Methods、Results及Discussion之縮寫）擴展為Tasi Mr Dr八字訣（題目、作者與機關、摘要、序論、材料與方法、結果、討論、及參考文獻），將之命名為現代科技八股文，融入傳統起承轉合四字訣的行文流程，讀者可使用此概念，用於文章寫作，或方便於寫作教學。

Stereotyped writing, or the eight-part essay, is a style of traditional Chinese writing specifically used for imperial examinations during the Ming and Qing dynasties. This writing style has some major flaws; however, the fixed format, including beginning, continuing, turning and concluding, may be useful in organizing other writing. This article provides a brief overview of stereotyped writing and applies its framework of beginning, continuing, turning and concluding to evaluate examples of writing from current medical journals. We introduce stereotyped writing to contemporary science and technology by expanding the IMRAD (Introduction, Methods, Results and Discussion) to TasiMrDr (an acronym for Title, Author/Affiliation, Summary/ Abstract, Introduction, Methods, Results, Discussion and References). We hope this method can be useful for writing and for teaching about writing methods.

1. (2009)。科技英文寫作。台北:五南。
2. 黃登山：中國古典詩文常用的結構起承轉合。2011年5月20日，取自http://www.obf.org.tw/new/learn/learn_03_03_3.htm.
3. 怎麼解釋古文中所應用的"啟、承、轉、合"。2011年5月20日，取自http://translate.google.com.tw/translate?hl=zh-TW&sl=zh-CN&u=http://zhidao.baidu.com/question/16612215&ei=JcfETbquOYmivgP4vLSrAQ&sa=X&oi=translate&ct=result&resnum=2&ved=0CCwQ7gEwAQ&prev=/search%3Fq%3D%25E5%2595%259F%25E6%2589%25BF%25E8%25BD%2589%25E5%2590%2588%26hl%3Dzh-TW%26biw%3D1012%26bih%3D453%26prmd%3Divns.
4. 莊榮輝：現代科舉與科技八股文。2011年5月20日，取自http://juang.bst.ntu.edu.tw/art%20science/daily10.htm.
5. 維基百科：八股文。2011年5月20日，取自http://zh.wikipedia.org/wiki/%E5%85%AB%E8%82%A1%E6%96%87.
6. Dans, A.M.,Villarruz, M.V.,Jimeno, C.A.(2007).The effect of Momordica charantia capsule preparation on glycemic control in type 2 diabetes mellitus needs further studies.J Clin Epidemiol,60,554-9.
7. Graham, T.E.,Yang, Q.,Bluher, M.(2006).Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects.N Engl J Med,354,2552-63.
8. Gu, D.,Reynolds, K.,Wu, X.(2005).Prevalence of the metabolic syndrome and overweight among adults in China.Lancet,365,1398-405.
9. Holvoet, P.,Lee, D.,Steffes, M.,Gross, M.,Jacobs, D., Jr.(2008).Association between circulating oxidized low-density lipoprotein and incidence of the metabolic syndrome.JAMA,299,2287-93.
10. Home, P.D.,Pocock, S.J.,Beck-Nielsen, H.(2007).Rosiglitazone evaluated for cardiovascular outcomes-an interim analysis.N Engl J Med,357,28-38.
11. Kahn, S.E.,Haffner, S.M.,Heise, M.A.(2006).Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy.N Engl J Med,355,2427-43.
12. Lewis, R.、Whitby, N.、Whitby, E.、劉華珍譯、李珮華譯(2011)。理科英文論文寫作。台北:眾文。
13. Nissen, S.E.,Wolski, K.(2007).Effect of rosiglitazone on the risk of myocardial in farction and death from cardiovascular causes.N Engl J Med,356,2457-71.
14. Petersen, K.F.,Dufour, S.,Hariri, A.(2010).Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease.N Engl J Med,362,1082-9.
15. Sanyal, A.J.,Chalasani, N.,Kowdley, K.V.(2010).Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis.N Engl J Med,362,1675-85.
16. Tsai, C.H.(2009).Metabolic syndrome in non-obese Taiwanese: new definition of metabolically obese, normal-weight individual.Chin Med J,122,2534-9.
17. Tsai, C.H.,Li, T.C.,Lin, C.C.(2008).Metabolic syndrome as a risk factor nonalcoholic fatty liver disease.South Med J,101,900-5.
18. Wascher, T.C.,Lindeman, J.H.,Sourij, H.,Kooistra, T.,Pacini, G.,Roden, M.(2011).Chronic TNF-alpha neutralization does not improve insulin resistance or endothelial function in "Healthy" men with metabolic syndrome.Mol Med,17,189-93.
19. Yazici, M.K.,Anil Yagcioglu, A.E.,Ertugrul, A.(2011).The prevalence and clinical correlates of metabolic syndrome in patients with schizophrenia: findings from a cohort in Turkey.Eur Arch Psychiatry Clin Neurosci,261,69-78.
20. Yeo, H.Y.,Kim, O.Y.,Lim, H.H.,Kim, J.Y.,Lee, J.H.(2011).Association of serum lycopene and brachial-ankle pulse wave velocity with metabolic syndrome.Metabolism,60,537-43.
21. Zheng, W.,McLerran, D.F.,Rolland, B.(2011).Association between body-mass index and risk of death in more than 1 million Asians.N Engl J Med,364,719-29.
22. 廖柏森(2006)。英文研究論文寫作─關鍵句指引。台北:眾文。

1. 蔡崇煌、黃素雲、張金堅、林哲鈺、林正介、李孟智、王俊堯(2016)。太極陰陽圖在西醫學解釋模型的創新應用。臺灣家庭醫學雜誌，26(4)，219-227。